ustekinumab
More Insight Into Anti-Interleukins
This month’s report focuses on the anti-interleukin treatments for inflammatory bowel disease, specifically ...
SEPTEMBER 21, 2023
In UC, Tofacitinib and Ustekinumab Perform Similarly After Biologic Failure
In biologic-experienced patients with ulcerative colitis, tofacitinib and ustekinumab achieve about the same rate ...
MAY 17, 2023
FDA Okays Stelara for UC
The FDA has approved the use of ustekinumab (Stelara, Janssen) for the treatment of moderate to severe ulcerative ...
OCTOBER 21, 2019
Load more